News

Home/News
News 2017-06-21T13:15:59+00:00
January 19, 2018
Aeglea BioTherapeutics to Present Preclinical Data at 2018 Keystone Symposia Tumor Metabolism Conference
AUSTIN, Texas, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a biotechnology company committed to the discovery and development of engineered human enzyme ...
January 19, 2018
Reata Announces the Publication of Efficacy Data From the Beacon Study of Bardoxolone in Diabetic CKD in the American Journal of Nephrology
IRVING, Texas, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced the digital publication of ...
January 19, 2018
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
RA'ANANA, Israel and NEW YORK, Jan. 18, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
January 19, 2018
HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock
TUCSON, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, ...
January 19, 2018
Santhera Plans to Announce Regulatory Feedback for Raxone® in DMD and 2017 Preliminary Key Financial Figures
Liestal, Switzerland, January 19, 2018 - Santhera Pharmaceuticals (SANN.SW) expects to announce feedback from the CHMP on its Marketing Authorization Application (MAA) for Raxone® in Duchenne ...
January 19, 2018
Zealand Pharma strengthens its Management by appointing Ivan Møller as SVP, Technical Development & Operations
Copenhagen, Denmark, January 19, 2018 - Zealand Pharma A/S ("Zealand") announces the appointment of Ivan Møller to a new position as Senior Vice President, Technical ...
January 18, 2018
AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for Exocrine Pancreatic Insufficiency
BROOKLYN, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant ...
January 18, 2018
Vermillion Announces Agreement with BlueCross BlueShield of Illinois
AUSTIN, Texas, Jan. 18, 2018 /PRNewswire/ -- ASPiRA Labs, a Vermillion company (VRML) and exclusive distributor of OVA1 (Multivariate Index Assay, or MIA), an ovarian cancer ...
January 18, 2018
Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) 2018 Annual Meeting
ROCKVILLE, Md., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment ...
January 18, 2018
Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock, offered at a ...
January 18, 2018
Paratek Announces Pricing of Public Offering of Common Stock
BOSTON, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
January 17, 2018
Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients
LIVONIA, Mich., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
January 17, 2018
Arcturus Therapeutics Announces Expansion of Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH) and Other GI Disorders
SAN DIEGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, announced today that it is extending its partnership ...
January 17, 2018
BioTime Announces Issuance of 41 New Patents to Expand and Bolster Its Patent Estate
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, today announced the issuance of 41 ...
January 17, 2018
VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901
CAMBRIDGE, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, ...
January 17, 2018
MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis
MARIETTA, Ga., Jan. 17, 2018 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue ...
January 17, 2018
First Chronic Hepatitis B Patient Dosed in China in a Phase 1 Trial of T101 (Transgene’s TG1050 Technology)
STRASBOURG, France-- (BUSINESS WIRE) -- Regulatory News: Transgene (TNG.PA) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announces that the first patient has ...
December 20, 2017
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-AAT
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it filed a regulatory submission to begin a first-in-human study of ARO-AAT, a second-generation investigational medicine ...
December 20, 2017
AzurRx BioPharma Announces Publication of U.S. Patent Application for AZX1101
BROOKLYN, N.Y., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc.(AZRX) (“AzurRx” or the “Company”), today announced that the United States Patent and Trademark Office ...
December 20, 2017
HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018
TUCSON, Ariz., Dec. 20, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents and services for molecular profiling applications, today ...
Page 1 of 48